1. Home
  2. NBIX vs ROKU Comparison

NBIX vs ROKU Comparison

Compare NBIX & ROKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • ROKU
  • Stock Information
  • Founded
  • NBIX 1992
  • ROKU 2002
  • Country
  • NBIX United States
  • ROKU United States
  • Employees
  • NBIX N/A
  • ROKU N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • ROKU Cable & Other Pay Television Services
  • Sector
  • NBIX Health Care
  • ROKU Telecommunications
  • Exchange
  • NBIX Nasdaq
  • ROKU Nasdaq
  • Market Cap
  • NBIX 14.4B
  • ROKU 14.6B
  • IPO Year
  • NBIX 1996
  • ROKU 2017
  • Fundamental
  • Price
  • NBIX $149.46
  • ROKU $105.37
  • Analyst Decision
  • NBIX Strong Buy
  • ROKU Buy
  • Analyst Count
  • NBIX 18
  • ROKU 20
  • Target Price
  • NBIX $172.06
  • ROKU $110.05
  • AVG Volume (30 Days)
  • NBIX 1.1M
  • ROKU 3.6M
  • Earning Date
  • NBIX 10-28-2025
  • ROKU 10-30-2025
  • Dividend Yield
  • NBIX N/A
  • ROKU N/A
  • EPS Growth
  • NBIX 12.44
  • ROKU N/A
  • EPS
  • NBIX 4.19
  • ROKU N/A
  • Revenue
  • NBIX $2,682,700,000.00
  • ROKU $4,543,395,000.00
  • Revenue This Year
  • NBIX $23.68
  • ROKU $16.00
  • Revenue Next Year
  • NBIX $18.02
  • ROKU $13.14
  • P/E Ratio
  • NBIX $35.79
  • ROKU N/A
  • Revenue Growth
  • NBIX 19.61
  • ROKU 16.61
  • 52 Week Low
  • NBIX $84.23
  • ROKU $52.43
  • 52 Week High
  • NBIX $157.67
  • ROKU $116.66
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 58.02
  • ROKU 57.93
  • Support Level
  • NBIX $133.62
  • ROKU $98.71
  • Resistance Level
  • NBIX $157.67
  • ROKU $108.79
  • Average True Range (ATR)
  • NBIX 5.06
  • ROKU 5.34
  • MACD
  • NBIX 0.91
  • ROKU 0.46
  • Stochastic Oscillator
  • NBIX 65.74
  • ROKU 49.49

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About ROKU Roku Inc.

Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.

Share on Social Networks: